Fernando Ortiz-Gonzalez

Moelndal, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Journal: Neurology

Published: July 13, 2026

Longitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progression.

Longitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progression.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 21, 2026

Interpreting p-tau217 on the ward: frailty and plasma biomarkers in acutely admitted older adults.

Interpreting p-tau217 on the ward: frailty and plasma biomarkers in acutely admitted older adults.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 23, 2026

Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease.

Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: February 20, 2026

Age-related increase in plasma p-tau217 in amyloid-beta-negative cognitively unimpaired individuals affects diagnostic interpretation.

Age-related increase in plasma p-tau217 in amyloid-beta-negative cognitively unimpaired individuals affects diagnostic interpretation.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 18, 2026

Blood-Based Analysis of Different Tau Variants in Patients With Multiple Traumatic Injuries.

Blood-Based Analysis of Different Tau Variants in Patients With Multiple Traumatic Injuries.

Journal: JAMA network open

Published: February 10, 2026

Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia.

Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia.

Journal: JAMA neurology

Published: February 02, 2026

Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use.

Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use.

Journal: Alzheimer's research & therapy

Published: November 27, 2025

Cerebrospinal fluid NPTX1 and NPTXR predict neurodegeneration and clinical progression in Alzheimer's disease.

Cerebrospinal fluid NPTX1 and NPTXR predict neurodegeneration and clinical progression in Alzheimer's disease.

Journal: Nature communications

Published: November 18, 2025

Comparative analysis of plasma p-tau217 immunoassays: challenges for standardization and harmonization.

Comparative analysis of plasma p-tau217 immunoassays: challenges for standardization and harmonization.

Journal: Clinical chemistry and laboratory medicine

Published: September 11, 2025

Biomarker-integrated prognostic stagings for Alzheimer's Disease.

Biomarker-integrated prognostic stagings for Alzheimer's Disease.

Journal: Nature communications

Published: September 06, 2025

Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease.

Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease.

Journal: Neurology

Published: August 19, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026